Subpotent drug
Subpotent drug
Consumers and healthcare providers should stop using this product immediately. Contact Avantor Performance Materials LLC or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Avantor Performance Materials recalls
Be the first to know. Free instant alerts to your inbox.
Magnesium Chloride, 6-Hydrate, Crystal, 500G per bottle, Bulk active pharmaceutical ingredient (API), Avantor Performance Materials, LLC, 100 Matsonford Road, Suite 200, Radnor, PA 19087, NDC 10106-2448-1. Reason: Subpotent drug. Classification: Class III. Quantity: 36 bottles. Distribution: Nationwide in the USA, Belgium and France
Not sure what to do next? Our guide walks you through the process step by step.
Read: How to Get Refunds and ReplacementsGet instant alerts for recalls that affect you. Free forever.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Lack of Assurance of Sterility
Failed Stability Specifications
K.C. Pharmaceuticals recalled eight OTC eye drops sold nationwide under CVS Health, Walgreens and Kroger brands after sterility could not be verified. The recall covers all lots within expiry through Oct 31, 2026. Nonsterile eye drops can harbor bacteria and fungus, causing serious infections that may lead to vision loss. Stop using recalled products and return them for a full refund at the store.
Biocon Pharma Inc. recalled 88,008 bottles of Prazosin Hydrochloride capsules, 1 mg, 100-count bottles, nationwide in the United States. A cGMP deviation detected N-nitroso-prazosin impurity C above acceptable limits. Consumers and healthcare providers should stop using this product immediately and contact Appco Pharma LLC or a healthcare provider for guidance.
Biocon Pharma Inc. recalled 28,157 bottles of PRAZOSIN HYDROCHLORIDE capsules, distributed nationwide in the USA. The recall cites cGMP deviation due to detection of N-nitroso-prazosin impurity C above acceptable limits. Stop using the product immediately and contact Appco Pharma LLC or your healthcare provider for guidance.
Biocon Pharma Inc. recalled 58,896 bottles of Prazosin Hydrochloride Capsules, USP, 2 mg, 100-count bottle. The product was distributed nationwide in the USA and manufactured by Appco Pharma LLC. A cGMP deviation detected N-nitroso-prazosin impurity C above acceptable limits. Consumers and healthcare providers should stop using this product immediately and contact Appco Pharma LLC or their health‑
Geri-Care eye drops recalled nationwide after lack of sterility assurance affects 720 bottles. The product, ARTIFICIAL TEARS with NDC 68788-7266-0, is manufactured by Preferred Pharmaceuticals, Inc. in Brooklyn, NY. The FDA recall class II points to a risk of contamination. Stop using immediately and contact a healthcare provider for guidance.